CTNM vs TXN · $429.6M cap vs P/E 52, rev $10.29B
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company listed on US.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ. It is led by Haviv Ilan.
Latest reported CTNM revenue for 2024-09-30 was $0. Net income was -$27.7M. CTNM currently screens at market cap $429.6M.
Latest reported TXN revenue for 2026-06-30 was $10.29B. Net income was $3.52B. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
CTNM currently screens at market cap $429.6M. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the CTNM and TXN stock pages for the full models.
Not investment advice.